Amplifica Announces First-in-Human Study Initiated
Amplifica’s AMP-303 safety and tolerability study targeting hair loss
Nature Publication Reveals Cutting-Edge Advancements in Understanding Hair Growth
Exclusive Licensing Agreement Allows for Access to Promising Early-Stage
Amplifica Expands Pipeline for Hair Loss
Exclusive Licensing Agreement Allows for Access to Promising Early-Stage ProteinSAN